Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Share Price
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 521.00 HKD | +0.39% |
|
+7.07% | +32.46% |
| Capitalization | 11TCr 12TCr 1.54TCr 1.31TCr 1.21TCr 1.14TCr 2.12TCr 1,44000Cr 2.16TCr 14TCr 5.54TCr 69TCr 5.8TCr 5.67TCr 2,45500Cr | P/E ratio 2025 |
-208x | P/E ratio 2026 * | -617x |
|---|---|---|---|---|---|
| Enterprise value | 10TCr 12TCr 1.5TCr 1.27TCr 1.17TCr 1.11TCr 2.06TCr 1,40000Cr 2.1TCr 14TCr 5.39TCr 67TCr 5.64TCr 5.52TCr 2,38700Cr | EV / Sales 2025 |
38.4x | EV / Sales 2026 * | 37.2x |
| Free-Float |
59.59% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | +0.10% | ||
| 1 week | +7.07% | ||
| Current month | +12.93% | ||
| 1 month | +24.94% | ||
| 3 months | +9.65% | ||
| 6 months | +9.74% | ||
| Current year | +32.46% |
| 1 week | 477.6 |  | 527.5 |
| 1 month | 389 | | 527.5 |
| Current year | 339.6 | | 527.5 |
| 1 year | 275 | | 581 |
| 3 years | 60.6 | | 581 |
| 5 years | 60.6 | | 581 |
| 10 years | 60.6 | | 581 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 54 | 01/03/2022 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 43 | 17/08/2022 |
Xiang Yang Tan
CTO | Chief Tech/Sci/R&D Officer | 63 | 05/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
CHM | Chairman | 75 | 01/03/2022 |
Jin Ping Jin
BRD | Director/Board Member | 54 | 15/02/2023 |
Yue Dong Li
BRD | Director/Board Member | 49 | 15/02/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | +7.07% | +79.76% | - | 1.54TCr | |
| 0.00% | +4.94% | +35.65% | +101.48% | 5.21TCr | |
| +0.26% | +2.98% | +103.18% | +24.51% | 4.72TCr | |
| -4.34% | -8.39% | +106.47% | +776.06% | 3.17TCr | |
| +1.08% | +8.03% | +0.47% | -23.28% | 2.52TCr | |
| +0.49% | +4.45% | +84.16% | -31.24% | 1.95TCr | |
| +0.76% | +2.69% | +43.32% | -36.28% | 1.78TCr | |
| +0.75% | +9.45% | +77.18% | +238.97% | 1.73TCr | |
| +1.29% | +12.28% | -14.22% | +1,245.22% | 1.64TCr | |
| -1.22% | -0.23% | +61.50% | +116.26% | 1.19TCr | |
| Average | -0.09% | +4.27% | +57.75% | +267.97% | 2.55TCr | |
| Weighted average by Cap. | -0.22% | +3.46% | +61.28% | +230.38% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 194.28Cr 223.23Cr 28Cr 24Cr 22Cr 21Cr 39Cr 2.66TCr 40Cr 261.04Cr 102.18Cr 1.28TCr 106.9Cr 104.66Cr 4.53TCr | 274.65Cr 315.57Cr 40Cr 34Cr 31Cr 30Cr 55Cr 3.75TCr 56Cr 369.02Cr 144.45Cr 1.8TCr 151.13Cr 147.96Cr 6.4TCr |
| Net income | -51Cr -59Cr -7.52Cr -6.37Cr -5.87Cr -5.54Cr -10Cr -700.66Cr -10Cr -69Cr -27Cr -336.38Cr -28Cr -28Cr -1.19TCr | -18Cr -20Cr -2.57Cr -2.18Cr -2.01Cr -1.9Cr -3.54Cr -239.98Cr -3.59Cr -24Cr -9.23Cr -115.21Cr -9.66Cr -9.46Cr -409.07Cr |
| Net Debt | -289.45Cr -332.58Cr -42Cr -36Cr -33Cr -31Cr -58Cr -3.96TCr -59Cr -388.91Cr -152.23Cr -1.9TCr -159.27Cr -155.94Cr -6.75TCr | -318.39Cr -365.83Cr -47Cr -40Cr -36Cr -34Cr -64Cr -4.35TCr -65Cr -427.8Cr -167.45Cr -2.09TCr -175.2Cr -171.53Cr -7.42TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 521.00 $ | +0.39% | 4,86,118 |
| 15/26/15 | 519.00 $ | +6.97% | 8,93,992 |
| 14/26/14 | 485.20 $ | -0.41% | 5,07,318 |
| 13/26/13 | 487.20 $ | -1.18% | 3,29,405 |
| 10/26/10 | 493.00 $ | +1.61% | 5,77,773 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6990 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition